UBS AG’s U.S. brokerage unit stopped selling leveraged exchange-traded funds, a fast-growing segment of the asset-management market that some regulators say might be inappropriate for individual investors.
UBS Wealth Management Americas suspended sales of inverse and leveraged ETFs immediately, citing the “short-term nature of these securities,” the New York-based unit said yesterday in a statement.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment